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Abstract: Real-time tracking of moving tumors is one of today’s challenges in radiation therapy. This 
work investigates the tracking performance of VERO, a novel treatment device with gimbaled linear 
accelerator, especially designed for four dimensional image guided radiotherapy. It is found that the 
significant impact of organ motion on dose distribution can be overcome by combining a polynomial 
predictor with a prediction horizon of 50ms with the VERO tracking system. Tracking errors can be 
reduced from 1.7mm to 0.6mm for realistic patient signals as well as sine wave from 5 to 30 bpm. 
Keywords: radiotherapy, tracking, measurements, position accuracy, medical robot 
1. INTRODUCTION 
In radiation therapy, intra-fraction motion results in 
significant geometric and dosimetric uncertainties in the 
therapeutic dose delivery treating thoracic and abdominal 
tumors. To accommodate these issues and to assure adequate 
dosimetric coverage of the tumor, geometric safety margins 
can be introduced which incorporate the entire motion. 
However, the use of large margins, where healthy tissues are 
present, prevents dose escalation as the dose to the healthy 
tissue would be a limiting factor. Tumour dose escalation has 
been shown to be  beneficial in terms of outcome (Wulf et al,
2005; McGarry et al, 2005; Komaki et al, 2005) when it can 
be combined with a decrease in excessive irradiation of 
surrounding normal tissue and critical structures to minimize 
complications (Kwa et al, 1998, Hernando et al, 2001). Beam 
modulation devices can help deliver complex radiation fields 
that can accurately conform to the PTV whilst at the same 
time sparing critical structures. The drawback of such 
treatments known as IMRT and to a lesser extent conformal 
radiotherapy is the presence of dose distribution with large 
gradient between the organs at risk and the tumor. If the 
tumor moves it could receive a significantly lower dose than 
planned and the organ at risk a significantly higher dose. 
Such event could negate the expected benefit of dose shaping 
and modulation. This paper focuses on one method to address 
organ motion referred to as real time tumor tracking (RTTT). 
RTTT is believed to be able to bring together the goals of 
dose escalation and surrounding tissue sparing for moving 
tumors.  
Most of the current RTTT solutions presented exploit
existing radiation therapy equipment in new ways to adapt 
the tumor motion to the therapeutic beam or adapt the beam 
to the tumor motion. A first approach is respiratory gating 
(Verellen et al, 2006) where the therapeutic beam is switched 
on only when the moving tumor is adequately covered and 
switched off otherwise. A drawback here is that the duty 
cycle usually is no more than 20 to 30 % which leads to very 
long treatment times. In an attempt to increase the duty cycle 
approaches like active breathing control (ABC) Wong et al,
1999) or breath-holding techniques Mah et al, 2000) have 
been used. However, patients affected by tumors in lungs and 
abdomen, where intra-fraction motion is most significant, 
may experience difficulties even with normal breathing, 
hence both breath-holding and ABC have limited 
applicability and may cause discomfort to the patients.  
The most technically challenging method with potentially the 
best result is to accommodate tumor motion during 
irradiation with a real-time tumor tracking radiation delivery 
system. The principle is that the tumor should stay in the 
same relative position with respect to the beam. This can be 
accomplished by continuous adaptation of the patient/tumor 
position using the patient support system (PSS) with respect 
to a static beam  or by real-time adaptation of the treatment 
beam itself to the tumor position. The technical feasibility of 
using a PSS to compensate for measurable tumour motion 
with respect to the treatment beam has been demonstrated 
(DeSouza et al , 2006, Skworcow et al, 2007, Wilbert J. et al,
2008). Whilst some studies seems to indicate that moving 
patient does not lead to any discomfort and can even be 
relaxing (Wilbert, 2008), the influence of counteracting part 
or all the motion on patient/tumor position behavior during 
this continuous repositioning requires further investigation. 
Indeed compensation of the motion in one direction may lead 
to a motion in another direction. Other approaches with a 
fixed patient position were presented where the dynamic 
behavior of the PSS were taken over by dynamic operation of 
the multi-leaf collimator (DMLC) (Keall et al, 2006, Sawant 
et al, 2008, Tacke et al, 2010) or a robotic-arm based linear 
accelerator gantry (Hoogemann et al, 2009). An important 
issue in DMLC tracking is the orientation of the tumor 
motion with respect to the leaf motion direction and the 
limited speed of the leafs. This introduces a difference in 
tracking performance between tracking a tumor moving
inline or perpendicular to the leaf trajectories.  The resulting 
combination of DMLC intensity modulation and arc therapy 
could potentially lead to unrealistic specifications for the 
MLC in terms of dynamics. A decoupling of the tracking 
motion and the DMLC based intensity modulation, such as 
that proposed in (Kamino et al, 2006), would therefore seem 
to be a more promising option. Such an approach has been 
adopted in the development and installation at UZ Brussel of 
the VERO system, a novel radiation therapy accelerator 
platform developed for image guided stereotactic body 
radiotherapy (SBRT). Key to the success of such system is its 
ability to actually track organ motion consistently with the 
required accuracy. The aim of this paper is to assess the 
tracking capabilities of the VERO system in terms of tracking 
errors, system tracking lag and the equivalence of pan and tilt 
gimbals motion. Section 2 of the paper describes the new 
device and the set up and material adopted to carry out the 
evaluation of the tracking performance of the machine. 
Section 3 presents the result with appropriate discussion and 
Section 4 provides a conclusion. 
2. MATERIALS AND METHODS 
VERO is a joint product of BrainLAB (BrainLAB AG, 
Feldkirchen, Germany) and MHI (Mitsubishi Heavy 
Industries, Tokyo, Japan) (Kamino et al, 2006). The VERO 
system is a small and light 6 MV C-band linac with an MLC 
mounted on an O-ring gantry. Two orthogonal gimbals hold 
the linac-MLC assembly, which allows pan and tilt motions 
of the linac and the therapeutic beam. This mechanism offers 
the possibility to perform real-time tracking of moving 
tumors, decoupled from the DMLC intensity modulation of 
the dose. The maximum excursion amplitude of the beam 
axis at the isocenter is 4.4 cm in the isocenter plane (or 2.5°) 
in both pan and tilt direction. Beside an EPID for MV portal 
imaging, the VERO system is equipped with two orthogonal 
kV Imaging systems attached to the O-ring at 45° from the 
MV beam axis. This imaging system allows simultaneous 
acquisition of orthogonal X-rays images and fluoroscopy. An 
ExacTrac (BrainLAB AG, Feldkirchen, Germany) automated 
infra-red (IR) marker based patient-positioning device is 
integrated into the VERO system.  
2.1  Experimental set up with the Quasar phantom 
A prototype of the real-time tumor tracking is currently 
installed on the system at UZB. This enables the VERO 
system to actively track an IR marker using the pan and tilt 
motion of the gimbals system. The VERO tracking prototype 
setup uses the Polaris camera of the BrainLAB ExacTrac 
system to track one IR marker in space. The gantry and O-
ring angles are 0° at all times and for this experiment the IR 
marker moves only in a horizontal plane at a source to axis 
distance (SAD) of 1000 mm. The MLC field size is set to 30 
by 30 mm and the light field of the system is switched on - 
see Fig. 1. This light field projects a square onto a sheet of 
paper perpendicular to the initial linac axis. Besides showing 
the beam position, the light field produces a shadow of the 
followed IR marker on the sheet of paper. The projection of 
light field and marker shadow are captured from below using 
a photo camera with movie function (Fig 1). This backlit 
video of the IR marker provides good contrast between the IR 
projection and the light field emitted by the machine in place 
of x-rays. The movie frames are acquired at a frame rate of 
30 fps and image size of 960x540 pixels. The MPEG movie 
frames are converted to bitmap files for further processing. 
Fig. 1: Experimental setup on the VERO system of the
Quasar phantom used to move an IR marker. A camera 
films the light field projection of the marker to identify 
the performance of the beam tracking. 
2.2  Hough transform for marker and light field tracking 
The frames of the movie are analyzed using a Hough 
transform based feature detection. The IR marker is detected 
as a circular object in the image, the field outline as a 
rectangular object. The centroid of the circle is taken as the 
position of the tracked IR marker object. The centroid of the 
detected rectangle determines the tracking beam position. For 
the detection of the tracked object and the tracking beam in 
the images, a Hough transform (Duda and Heart, 1972) based 
feature detection algorithm was developed, see Fig. 2. The 
algorithm includes an edge detector which detects the 
boundary of the regions of interest by considering the grey 
levels and applying a threshold. It is followed by a Hough 
transforms for a circle and a rectangle. The IR marker 
shadow and the rectangular light field is given by the 
maximum intensity within the Hough transform images . To 
Camera
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with moving 
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Light field projection 
filmed by the camera  
allow sub-pixel accuracy an average value was calculated 
over the 5 highest values in the Hough transform. To verify 
the Hough transform feature detection accuracy, video 
images of the tracked IR marker and the tracking beam were 
acquired with the tracking mode and Quasar phantom motion 
switched off. A total of 100 image frames were analyzed with 
the feature detection algorithm. The standard deviations of 
the detected circle and rectangle positions were respectively 
0.06 mm and 0.04 mm in the static case which was 
considered adequate.  
             
Fig. 2.  Illustration of the Hough Transform applied to the 
backlit moving target and light field 
2.3  Tracking motion implementation  
To determine the tracking error, an IR marker was placed on 
the moving part of the Quasar phantom (Modus Medical
Devices, London, Canada). A trajectory from a patient as 
well as a set of one-dimensional sinusoidal motion were 
produced by the phantom with different frequencies ranging 
from 5 breaths-per-minute (bpm) (0.085Hz) to 30 bpm
(0.5Hz), and a fixed amplitude of 20 mm. The 30 bpm in 
combination with the 20 mm amplitude reaches the maximal 
tracking speed of 60 mm/s. The VERO tracking system
makes use of a polynomial predictor to anticipate the position 
of the target being tracked. In this work, a 3rd order 
polynomial prediction function was selected with a prediction 
horizon set to 20 ms, 35 ms and 50 ms for all frequencies. To 
quantify the system lag and be used as a reference a
measurement was performed without any form of prediction 
(i.e. prediction time set to 0 ms). The experiment was 
performed separately for the X direction or pan and for the Y 
direction or tilt. The motion of tracked object and tracking 
beam were recorded simultaneously with the camera system 
and analyzed with the feature detection algorithm. 
2.4   Tracking error and dose blurring  
To investigate the relationship between tracking error and 
dose blurring larger tracking errors were introduced by 
temporarily reducing the maximum tracking speed from 60 
mm/s to 25 mm/s. In a first step the tracking errors were 
determined in a way identical to what is described in the 
previous section, using sinusoidal motions of the Quasar 
phantom. Subsequently the experiment was repeated with the 
6 MV beam in tracking mode irradiating an EBT2 
radiochromic film inserted in the moving part of the Quasar 
phantom. Tracking errors result in blurring of the dose 
distribution. As such a relationship can be established 
between tracking error and dose blurring due to residual 
motion of the tracking beam relative to the tumor. Dose 
blurring was quantified in terms of the penumbra width. 
3. RESULTS 
The prototype system lag was calculated from the phase shift 
between the motion of the tracking beam and the motion of 
the tracked object for a prediction time set to 0 ms. An 
average was calculated over all applied sinus frequencies 
from 5 bpm to 30 bpm. A system lag was determined to be 
47.7 ms (SD 2.3 ms) and 47.6 ms (SD 2.0 ms) for the X and 
Y direction respectively. For a forward prediction time of 50 
ms, the remaining system lag was -0.2 ms (SD 7.1 ms).  
The tracking error was characterized in terms of systematic 
error, root mean square error (RMSE) and 90% percentile of 
the absolute tracking error values (E90%) each calculated 
over a whole number of sinus periods. The maximal 
systematic errors, calculated as the average of the difference 
between tracked object and tracking beam position, were 
below 0.2 mm for all motion sequences. The RMSE and
E90% values are shown in Fig. 3 and Fig. 4 for the range of 
frequencies and for the different forward prediction times.  
Fig. 3: The root-mean-square tracking error for a range of 
sinus motions with frequencies from 5 bpm to 30 bpm, for 
different forward prediction times 0 ms, 20 ms, 35 ms and 
50 ms, in X and Y direction 
Fig. 4: The 90% percentile (E90%) of the absolute tracking 
error for a range of sinus motions with frequencies from 5 
bpm to 30 bpm, for different forward prediction times 0 
ms, 20 ms, 35 ms and 50 ms, in X and Y direction 
Without forward prediction, the tracking error is strongly 
dependent on the motion frequency and values of up to 1.84 
mm and 2.98 mm for X and 1.60 mm and 2.99 mm for Y 
were seen for RMSE and E90% respectively. Compensating 
the system lag with a forward prediction gimbals control of 
50 ms reduced both maximum values of RMSE and E90% 
respectively to 0.29 mm and 0.59 mm for X, and 0.41 mm 
and 0.82 mm for Y. 
Fig. 5 and 6 illustrate the dynamic behaviour of the beam as 
well as the reference surrogate marker for the Y axis of 
motion. In this case a signal obtained from a patient, with an 
average breathing frequency of 19.1 bpm, was used to
provide a realistic range of motion and acceleration. Fig. 5 
illustrates the tracking achievable without prediction. Fig. 6 
illustrates the improvement that can be achieved with a 
forward prediction of 50 ms. The RMSE and E90% were
respectively 0.95 mm and 1.37 mm without forward 
prediction, and 0.20 mm and 0.37 mm for 50 ms forward 
prediction. The tracking behaviour in the X direction for this 
motion sequence was similar. 
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Fig. 5: The movement, tracking error and speed for a patient 
signal without forward prediction 
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Fig. 6: The movement, tracking error and speed for a patient 
signal with 50 ms forward prediction 
To evaluate the dosimetric effect of the tracking errors an 
irradiation was carried out where one film was taken without 
any target motion one without any correction and one using 
tracking with 50ms prediction illustrated in the left, right and 
centre film represented in Fig. 7 respectively.  
         a) Immobile          b) Tracked            c) Not tracked 
Fig. 7: Illustrating the improvement achievable using tracking 
Fig. 8 illustrates the influence of the speed of the surrogate 
marker on the tracking performance in terms of the width of 
the penumbra region in mm (dose between 20 and 80%) and 
the high dose region in cm (dose above 80%), determined on 
a line scan inline with the phantom motion direction. To 
introduce large tracking errors in this experiment the 
maximum tracking speed of the prototype was temporarily 
reduced from 60 mm/s to 25 mm/s. The effect on the 
irradiation becomes noticeable above 15 bpm when the
tracking error is in the order of 1mm RMSE and 1.5mm
E90%, because the maximal tracking speed of 25 mm/s is 
reached. 
Fig. 8: Illustrating the effect of the number of breath per 
minute and the speed of the target being tracked on the 
tracking error in terms of blurring of the dose resulting in 
increased penumbra (in mm) and reduced high dose 
region (in cm). 
4. DISCUSSION AND CONCLUSIONS 
A prototype of a gimbals based tracking system has been 
tested on a VERO linear accelerator system. It is able to 
pursue one IR marker in space with the therapeutic beam. To 
characterize the tracking performance of the system a series 
of experiments were conducted to quantify the system
latency, tracking error and the equivalence of X and Y 
motions. The combination of the total system lag of the 
ExacTrac IR tracking and the gimbals response was 
experimentally determined to be 47.7 ms. This was in
agreement with the sum of the loop sub-system latencies 
determined independently by the vendor: IR marker position 
acquisition of 25 ms, gimbals position calculation 2 ms, 
gimbals control cycle time of 20 ms. For a comparable 
DMLC tracking setup, using the Varian RPM IR system and 
Millenium MLC 120 (Varian MS, Palo Alto, CA, US), Keall 
et al. (2006) have reported a considerably larger total system 
lag of 160 ms. The IR marker acquisition times were
comparable to the ones for ExacTrac, 33 ms versus 25 ms. 
The MLC control cycle time is 50 ms compared to 20 ms for 
the VERO gimbals. The leaf position calculation also
requires more CPU time than calculation of the gimbals 
position update. Tacke et al.( 2010) have described another 
DMLC solution based on a Siemens 160 MLC (Siemens AG, 
Erlangen, Germany) which showed to have a system lag of 
over 400 ms. The total system latency reported for the 
CyberKnife (Accuray Inc., Sunnyvale, CA, US) robotic-arm 
based linear accelerator gantry was 192.5 ms (Hoogeman et 
al, 2009).  
For quantification of the system lag, all the above mentioned 
tracking loops use an IR based tumor position monitoring 
with low latencies. These devices and prototypes are not 
tracking the tumor motion directly based on internal
anatomical information or implanted fiducial markers. 
Clinical tracking systems will most probably use X-ray 
fluoroscopy for direct tumor tracking, however, not as a sole 
method because of the extensive imaging dose exposure. The 
report of AAPM Task Group 76 (Keall et al. 2006) provides 
an estimate of fluoroscopy exposure to track fiducial gold 
markers. A dose of 0.18 mGy per image was determined to 
allow robust detection of the fiducials. If, for example, a 
stereotactic lung treatment is considered of 15 Gy per 
fraction, delivering 1500 MU in total with a dose rate of 500 
MU/min, this requires 180 s of beam on. A frame rate of 5 
times a stereo image per second would result in a 
considerable imaging exposure of about 0.3 Gy per fraction, 
primarily of healthy tissues. To overcome this issue, hybrid 
tumor tracking systems have been proposed, see for example 
(Hoogeman, 2009), which combine limited X-ray 
fluoroscopy tracking of internal markers/anatomy with 
tracking of breathing motion through external markers. 
Before the treatment delivery is initiated, simultaneous 
acquisition with both techniques is performed during a 
calibration sequence and a correlation model between
external marker and internal marker motion is determined. 
The approach during treatment is to use the external markers 
to feed the actual tumor tracking, but verify at regular time 
points during treatment the validity of the correlation model 
with the acquisition of fluoroscopic images. A recalibration 
of the correlation model can be done during treatment if 
needed. In that respect, the system latency determined for the 
currently installed prototype tracking based on external IR 
markers can be considered relevant for the future clinical 
released versions of the VERO tracking module when using 
this hybrid approach.  
Real-time tumor tracking using fluoroscopy directly requires 
a trade-off between different parameters. The additional 
imaging dose for the patient is determined by the acquisition 
repetition rate and by the image quality required to allow fast 
and robust detection of anatomy or implanted fiducials in the 
images. Low fluoroscopy frame rates will decrease tumor 
motion temporal information. Additionally, X-ray image 
acquisition and analysis calculation times will introduce 
additional system latency in the feedback loop of about 100 
ms. Consequently more advanced algorithms for forward 
prediction will be required which perform well for longer 
prediction horizons. Further research is required to optimize 
the balance between adequate temporal information, robust 
detection and imaging dose for treatment of moving tumors 
with fluoroscopy based tracking. 
The tracking error has been quantified for a set of sinusoidal 
signals with different frequencies. The error was expressed in 
both RMSE and E90%. For both metrics increased tracking 
error was seen in case of inadequate forward prediction. The 
most appropriate prediction horizon was experimentally 
found to be 50ms in order to compensate the overall system’s 
latency. The current prototype was able to track the IR 
marker sinusoidal motion accurately up to frequencies of 30 
bpm (0.5 Hz) with an E90% < 0.59 mm in X direction and 
E90% < 0.82 mm in Y direction. The tracking performance in 
X and Y direction was found to be equivalent. The physical 
decoupling of the leaf motion and the tracking motion is 
advantageous compared to DMLC tracking where substantial 
differences may arise between tracking of fast moving tumors 
inline and perpendicular to the MLC leaf trajectories 
(Sawant, 2008). 
The 20 mm amplitude, 30 bpm sinus signal reaches a 
maximum speed of 20 mm/s which is even slightly 
exceeding the currently set maximum gimbals tracking speed 
of 60 mm/s. Patient signals usually consist of a first harmonic 
of below 0.25 Hz, but also contain higher harmonics and 
noise. As an illustration patient signal with a clinically 
relevant amplitude and frequency was applied to the Quasar 
phantom and tracked by the gimbals. For this particular 
patient the maximum speed was approximately 40 mm/s.
With compensation of the system lag the tracking error was 
reduced to an E90% of 0.37 mm and RMSE of 0.20 mm. The 
maximum tracking error was reduced from 1.70 mm to 0.60 
mm. Compared to previous reports on tracking errors with 
DMLC and robotic arm gantry real-time tracking, these 
preliminary values are promising, however, more verification 
is required on an extended patient dataset. In addition, the 
relationship between tracking error and dosimetric coverage 
of the tumor needs to be thoroughly investigated to establish 
certain minimum constraints on tracking error for clinical 
application. 
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